Imbed Biosciences key facts
as of Oct 2026- Developer of an advanced wound care device designed to protect wounds and support the healing process across acute and chronic conditions.
- Imbed Biosciences is valued at approximately $15.7M as of Oct 2026 (last reported valuation).
- It has raised $40.0M across 8 recorded rounds; the latest was Seed Round ($3.5M) in Dec 2023.
- Notable investors include US National Science Foundation, National Institutes of Health, Pegasus Tech Ventures, WARF Ventures, Francis Family Fund — 15 tracked in total.
- Imbed Biosciences has filed 10 Form Ds with the SEC since 2014, most recently Dec 2023 ($3.5M sold to 1 investors).
- Status: Privately Held (backing).
Imbed Biosciences's last reported valuation, Oct 2019. Nothing priced has surfaced since.
- ·The complete investor list: 15 names
- ·Watch Imbed Biosciences: the Monday email on marks, rounds and moves
Imbed Biosciences funding rounds
8 roundsWho backs Imbed Biosciences
15+Membership and data by Private Market View
Imbed Biosciences valuation
Imbed Biosciences's last reported valuation was $15.7 million in Oct 2019. No priced round, secondary trade or fund mark has surfaced since.
How much has Imbed Biosciences raised?
Imbed Biosciences has raised $40 million across 8 recorded rounds since 2014. The largest was a $7.9 million early-stage round in Nov 2021; the most recent was a $3.5 million seed round in Dec 2023.
Imbed Biosciences has filed 10 Form Ds with the SEC since 2014, most recently in Dec 2023 ($3.5 million sold to 1 investor).
Imbed Biosciences investors
15 investors are on record for Imbed Biosciences, including US National Science Foundation, National Institutes of Health, Pegasus Tech Ventures and WARF Ventures. The seed round in Dec 2023 drew 1 investor.
About Imbed Biosciences
Developer of an advanced wound care device designed to protect wounds and support the healing process across acute and chronic conditions. The company offers ultra-thin, fully synthetic, bioresorbable wound matrices that combine multiple active wound care components, including broad-spectrum antimicrobial agents and targeted pain relief compounds, within a flexible and conformable polymer structure, enabling healthcare providers and care settings to manage bioburden, reduce discomfort, and support effective healing across surgical, traumatic, burn, and chronic wounds.
- Sector
- Healthcare
- HQ
- Middleton, WI, United States
- Founded
- 2010
- Employees
- 30
- Website
- imbedbio.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.